Receptor Tyrosine Kinases as Candidate Prognostic Biomarkers and Therapeutic Targets in Meningioma
Meningioma (MGM) is the most common type of intracranial tumor in adults. The validation of novel prognostic biomarkers to better inform tumor stratification and clinical prognosis is urgently needed. Many molecular and cellular alterations have been described in MGM tumors over the past few years,...
Enregistré dans:
Auteurs principaux: | Rafael Roesler, Barbara Kunzler Souza, Gustavo R. Isolan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cf5a5bd28c35447baf38e34d1f7122fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of HER2 receptor status on axillary nodal burden in patients with non-luminal A invasive ductal breast carcinoma
par: Kustic,Domagoj, et autres
Publié: (2019) -
Relación entre la amplificación del oncogén C-erbB-2 y parámetros histológicos con sobrevida libre de enfermedad en pacientes con cáncer de mama
par: Rojas-Atencio,Alicia E., et autres
Publié: (2005) -
Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs
par: Louise Pinet, et autres
Publié: (2021) -
Isolated Intraconal Meningioma
par: Mohammad Taher Rajabi, et autres
Publié: (2021) -
Surgical Management of Intracranial Meningiomas in the Elderly: Early and Long-term Outcomes
par: Czernicki T
Publié: (2020)